Scott L Burrows
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $9.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 17,50079,762 held (−18%) | $89.89 | $1.6M | -4.7% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 60086,662 held (−1%) | $89.07 | $53K | -3.8% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 1,50085,162 held (−2%) | $90.27 | $135K | -5.1% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 2,10083,062 held (−2%) | $91.92 | $193K | -6.8% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 3,07179,991 held (−4%) | $92.95 | $285K | -7.8% |
| Oct 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 22979,762 held (−0%) | $93.57 | $21K | -8.4% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 900104,594 held (−1%) | $86.25 | $78K | -0.6% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 4,384100,210 held (−4%) | $87.11 | $382K | -1.6% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 2,01698,194 held (−2%) | $88.03 | $177K | -2.7% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 20097,994 held (−0%) | $89.04 | $18K | -3.8% |
| Sep 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 18,23279,762 held (−19%) | $89.35 | $1.6M | -4.1% |
| Aug 5SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 5,100100,394 held (−5%) | $95.21 | $486K | -10.0% |
| Aug 5SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 2,30098,094 held (−2%) | $96.30 | $221K | -11.0% |
| Aug 5SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 10097,994 held (−0%) | $97.10 | $10K | -11.8% |
| Jul 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 5,77599,719 held (−5%) | $87.55 | $506K | -2.1% |
| Jul 2SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 1,72597,994 held (−2%) | $88.37 | $152K | -3.0% |
| Jun 26SEC | SYRESpyre Therapeutics, Inc. | Sell | 5,000107,994 held (−4%) | $87.12 | $436K | -1.6% |
| Jun 26SEC | SYRESpyre Therapeutics, Inc. | Sell | 10,00097,994 held (−9%) | $87.14 | $871K | -1.7% |
| Jun 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 1,801103,693 held (−2%) | $69.75 | $126K | +22.9% |
| Jun 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 2,599101,094 held (−3%) | $70.77 | $184K | +21.1% |
| Jun 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 3,10097,994 held (−3%) | $72.06 | $223K | +18.9% |
| May 1SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 12,50097,994 held (−11%) | $71.37 | $892K | +20.1% |
| Apr 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 6,20099,294 held (−6%) | $49.21 | $305K | +74.1% |
| Apr 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 1,30097,994 held (−1%) | $49.98 | $65K | +71.4% |
| Mar 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 2,30098,194 held (−2%) | $40.56 | $93K | +111.3% |
| Mar 3SEC | SYRESpyre Therapeutics, Inc. | Sell Plan | 20097,994 held (−0%) | $41.66 | $8K | +105.7% |
- Sell
CFO Scott L Burrows sold $1.6M of SYRE at $89.89 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott L Burrows sold $53K of SYRE at $89.07 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott L Burrows sold $135K of SYRE at $90.27 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott L Burrows sold $193K of SYRE at $91.92 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott L Burrows sold $285K of SYRE at $92.95 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Scott L Burrows sold $21K of SYRE at $93.57 — pre-scheduled 10b5-1 plan sale.